• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
WND

WINDLAB LIMITED - Announcements

0.61% ! $1.66
Currently unlisted. Proposed listing date: 23 AUGUST 2017
Add to My Watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements



Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
refresh Created with Sketch. REFRESH
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Top Stories

Diablo: Horn Silver acquisition approved, maiden Star Range drilling set to commence

Diablo Resources CEO Lyle Thorne joins HotCopper to discuss acquisition of the historic Horn Silver in Utah, as well as final drill permits.
LISTEN: HotCopper Wire Podcast #053 – Safer bet to put cash in Pokémon trading cards In this week’s HotCopper Wire episode, Isaac McIntyre and Jonathon Davidson break down XHJ’s booming revival (and Pokémon trading cards), as well as Richard White leaving WiseTech (ASX:WTC), and what flagging auction clearance rates Down Under mean for the HotCoppe...
LISTEN: HotCopper Wire Podcast #052 – Finger lickin' not so good In this week’s HotCopper Wire episode, Isaac McIntyre and Jonathon Davidson talk about all the inflation data that’s come out in Australia this week and whether the Reserve Bank will go for another hike in August, as well as the H5 bird flu scare in WA @ and what t...
Australia's resources and energy exports remain strong, despite Middle East crisis The AI investment boom is helping to generate demand for Australia’s resources and energy commodities according to new federal data.
Syntara shows encouraging first signals it can impact the path to Parkinson's Syntara (ASX:SNT) has reported encouraging interim results from its Phase 2 study of SNT-4728, providing the first clinical evidence that the company’s novel anti-inflammatory therapy may be targeting a key biological process linked to the development of Parkinson’...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.